CClinicalTrials.gg
CompletedNCT06467162Updated Jun 20, 2024

Usage of Spacers and the Relationship With Symptoms Severity in COPD Elderly Patients

An observational study in Pulmonary Disease and Chronic Obstructive, sponsored by Ai-Ling Chang. Completed at 1 site in Taiwan. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2024-06-20.

Sponsored by Ai-Ling Chang · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
164
Ages
65 Years and older
Sex
All
01

Study summary

The goal of this observational study is to investigate the usage of spacers and their relationship with symptom severity in chronic obstructive pulmonary disease elderly patients. Patients with chronic obstructive pulmonary disease aged 65 years or over at thoracic medicine outpatient clinics were recruited in this study. Research participants were interviewed using structured questionnaires, including demographic characteristics information, clinical characteristics information, and the chronic obstructive pulmonary disease assessment test.

Read the detailed description

The goal of this observational study is to investigate the usage of spacers and their relationship with symptom severity in chronic obstructive pulmonary disease elderly patients. A convenience sample was used to recruit patients with chronic obstructive pulmonary disease aged 65 years or over at thoracic medicine outpatient clinics from a teaching hospital in Taiwan. Research participants were interviewed using structured questionnaires, including demographic characteristics information, clinical characteristics information, and the chronic obstructive pulmonary disease assessment test.

02

Conditions studied

  • Pulmonary Disease
  • Chronic Obstructive

Browse trials for

Keywords

  • Chronic Obstructive Pulmonary Disease
  • Spacer
  • Symptom severity
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 164 is close to the median of 157 across 929 observational studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

Ai-Ling Chang is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with chronic obstructive pulmonary disease aged 65 years or over at thoracic medicine outpatient clinics.

Inclusion criteria

  • Individuals aged 65 or above diagnosed with COPD by a pulmonologist.
  • Clear consciousness and communication abilities in Mandarin or Taiwanese.
  • Consent to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion Criteria:

  • Patients who are blind, deaf, unable to express themselves, and unable to understand the study explanation.
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
164 participants (actual)
Patient registry
No

Groups and cohorts

  • observational group

    Research participants were interviewed using structured questionnaires, including demographic characteristics information, clinical characteristics information, and the chronic obstructive pulmonary disease assessment test.

06

What researchers measure

Primary outcomes

  1. Symptoms severity

    The severity and impacts of the COPD symptoms were measured by using the chronic obstructive pulmonary disease assessment test

    Time frame: Immediately after the outpatient department visit

07

Study locations

1 site
  • Wan-Ting Huang
    Changhua, 51591, Taiwan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06467162
Lead sponsor
Ai-Ling Chang
Responsible party
Ai-Ling Chang (Supervisor, Changhua Christian Hospital) — Sponsor-investigator
First posted
Jun 20, 2024
Start date
Apr 6, 2023
Primary completion
Jun 30, 2023
Completion
Jun 30, 2023
Last update
Jun 20, 2024

Study contacts

Wan-Ting Huang, PhD
study chair · Da-Yeh University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion